Skip to main content
SpringerLink
Log in

Blue Fog

Citalopram, methylene blue, serotonin syndrome

  • Chapter
A Case Approach to Perioperative Drug-Drug Interactions

  • 100 Accesses

Abstract

This case discusses a pharmacodynamic interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.

    Article  PubMed  CAS  Google Scholar 

  2. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13:100–9.

    Article  PubMed  CAS  Google Scholar 

  3. Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51:194–200.

    Article  PubMed  Google Scholar 

  4. Methylthioninium chloride (methylene blue): update on CNS toxicity with serotonergic drugs. Drug Safety Update. 2009;2:3.

    Google Scholar 

  5. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol. 2007;152:946–51.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  6. Schwiebert C, Irving C, Gillman PK. Small doses of methylene blue, previously considered safe, can precipitate serotonin toxicity. Anaesthesia. 2009;64:924.

    Article  PubMed  CAS  Google Scholar 

  7. FDA Drug Safety Communication: updated information about the drug interaction between methylene blue (methylthioninium chloride) and serotonergic psychiatric medications. http://www.fda.gov/Drugs/DrugSafety/ucm276119.htm. Last accessed 12 Dec 2011.

  8. Product information: Methylene Blue Injection USP 1 % American Regent Inc. Rev. 3/11

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Toby N. Weingarten MD, Wayne T. Nicholson MD, PharmD, MSc & Juraj Sprung MD, PhD

Authors
  1. Toby N. Weingarten MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wayne T. Nicholson MD, PharmD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Juraj Sprung MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toby N. Weingarten MD .

Editor information

Editors and Affiliations

  1. Anesthesia Services Department, Philadelphia Veterans Affairs Med Center, Philadelphia, PA, USA

    Catherine Marcucci MD

  2. Department of Anesthesiology, Oregon Health and Science University, Portland, OR, USA

    Michael P. Hutchens MD

  3. Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA

    Erica D. Wittwer MD, PhD , Toby N. Weingarten MD , Juraj Sprung MD, PhD  & Wayne T. Nicholson MD, PharmD, MSc , ,  & 

  4. Department of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Kirk Lalwani MD

  5. Department of Anesthesiology, University of Pittsburgh School of Med Liliane S. Kaufmann Building, Pittsburgh, PA, USA

    David G. Metro MD

  6. Department of Anesthesiology, University of Illinois at Chicago, Chicago, IL, USA

    Randal O. Dull MD, PhD

  7. Department of Anesthesiology, Perioperative Medicine, Oregon Health and Science University, Portland, OR, USA

    Christopher E. Swide MD

  8. Department of Learning Health Sciences, University of Michigan Medical School, Ann Arbor, MI, USA

    F. Jacob Seagull PhD

  9. Department of Anesthesiology and Perioperative Medicine, Portland, OR, USA

    Jeffrey R. Kirsch MD (Professor and Chair) (Professor and Chair)

  10. Department of Psychiatry, University of Maryland Medical System VA Maryland Health Care System, Baltimore, MD, USA

    Neil B. Sandson MD

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Weingarten, T.N., Nicholson, W.T., Sprung, J. (2015). Blue Fog. In: Marcucci, C., et al. A Case Approach to Perioperative Drug-Drug Interactions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7495-1_175

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7495-1_175

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7494-4

  • Online ISBN: 978-1-4614-7495-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation